{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:31:58Z","timestamp":1785727918015,"version":"3.56.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.eplepsyres.2021.106780","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:38:26Z","timestamp":1633153106000},"page":"106780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis"],"prefix":"10.1016","volume":"177","author":[{"given":"Julien","family":"Neveu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Milh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-8564","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Desnous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106780_bib0005","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1528-1167.2010.02594.x","article-title":"Serotonin reuptake inhibitors are associated with reduced severity of ictal hypoxemia in medically refractory partial epilepsy","volume":"51","author":"Bateman","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1542\/peds.2003-1151-L","article-title":"Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control","volume":"114","author":"Berg","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2019.05.011","article-title":"Immediate outcomes in early life epilepsy: a contemporary account","volume":"97","author":"Berg","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0020","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.45.10.1926","article-title":"Anticonvulsant effect of fluoxetine in humans","volume":"45","author":"Favale","year":"1995","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2021.106780_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yebeh.2005.07.014","article-title":"The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant","volume":"7","author":"Jobe","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0040","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1038\/tp.2016.25","article-title":"Is increased antidepressant exposure a contributory factor to the obesity pandemic?","volume":"6","author":"Lee","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0045","unstructured":"Prozac. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0278605.htm."},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0050","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1212\/WNL.0000000000008741","article-title":"Clinical risk factors in SUDEP: a nationwide population-based case-control study","volume":"94","author":"Sveinsson","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","article-title":"Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression","volume":"10","author":"Thome-Souza","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106780_bib0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ejpn.2017.04.001","article-title":"Heterogeneity of FHF1 related phenotype: novel case with early onset severe attacks of apnea, partial mitochondrial respiratory chain complex II deficiency, neonatal onset seizures without neurodegeneration","volume":"21","author":"Villeneuve","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:46:52Z","timestamp":1760276812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":12,"alternative-id":["S0920121121002333"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106780","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106780"}}